About MedNext

Editorial Review Process

Accuracy is a clinical requirement, not a feature. Our editorial process is designed to meet the standard expected of a tool used at the point of care.

• MedNext Audited Proprietary Clinical Dataset

  All drug monographs are compiled from the MedNext Audited Proprietary Clinical Dataset — a curated, internally maintained pharmacological reference that undergoes structured editorial oversight before publication.

• Clinical review before publication

  Every drug entry is reviewed by a clinician prior to being made available in the app. Entries are not generated automatically or published without human oversight.

• Regular updates to reflect current practice

  The dataset is updated on a continuous basis to reflect changes in approved dosing, new safety signals, and evolving prescribing guidance relevant to the UK and international clinical contexts.

• Cross-referenced against authoritative pharmacological sources

  Monograph content is cross-referenced against multiple authoritative pharmacological and clinical sources to ensure internal consistency and accuracy across drug classes.

• Interaction data verified against pharmacological evidence

  Drug interaction data is verified against known pharmacokinetic and pharmacodynamic evidence. Interaction severity classifications are assigned based on clinical relevance and published evidence of harm.